Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-06-09 Purchase | 2020-06-11 8:15 pm | Aevi Genomic Medicine LLC | CERC | COLA MICHAEL F Chief Executive Officer | 100,000 | $2.5 | $250,000 | 175,746 (Direct) | View |
| 2019-12-19 Purchase | 2020-02-07 12:58 pm | Aevi Genomic Medicine Inc. | GNMX | ASTRAZENECA PLC MedImmune Ltd 10% Owner | 12,946,900 | $0 | $0 | 12,946,900 (Indirect) | View |
| 2019-12-05 Purchase | 2019-12-09 9:15 pm | Aevi Genomic Medicine Inc. | GNMX | COLA MICHAEL F President and CEO | 2,049,376 | $0.134 | $274,616 | 2,267,859 (Direct) | View |
| 2019-12-05 Purchase | 2019-12-09 9:12 pm | Aevi Genomic Medicine Inc. | GNMX | NEIL GARRY ARTHUR Chief Scientific Officer | 2,049,376 | $0.134 | $274,616 | 2,164,150 (Direct) | View |
| 2019-12-05 Sale | 2019-12-09 9:10 pm | Aevi Genomic Medicine Inc. | GNMX | BARER SOL J Director | 4,098,752 | $0.134 | $549,233 | 5,102,040 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2020-02-07 12:57 pm | N/A N/A | Aevi Genomic Medicine Inc. | GNMX | ASTRAZENECA PLC MedImmune Ltd 10% Owner | 0 | $0 | 12,946,900 (Indirect) | View |
| 2020-02-03 Disposition | 2020-02-05 4:25 pm | N/A 2023-09-13 | Aevi Genomic Medicine Inc. | GNMX | BARER SOL J Director | 844,912 | $0 | 0 (Direct) | View |
| 2020-02-03 Disposition | 2020-02-05 4:24 pm | N/A 2026-07-29 | Aevi Genomic Medicine Inc. | GNMX | McInaw Michael Interim CFO | 66,857 | $0 | 16,107 (Direct) | View |
| 2020-02-03 Disposition | 2020-02-05 4:23 pm | N/A 2028-04-17 | Aevi Genomic Medicine Inc. | GNMX | Duncan Barbara Gayle Director | 200,115 | $0 | 0 (Direct) | View |
| 2020-02-03 Disposition | 2020-02-05 4:21 pm | N/A 2027-12-04 | Aevi Genomic Medicine Inc. | GNMX | Bayley Matthew D Director | 90,000 | $0 | 0 (Direct) | View |
| 2020-02-03 Disposition | 2020-02-05 4:20 pm | N/A 2024-01-02 | Aevi Genomic Medicine Inc. | GNMX | GRANO JOSEPH J JR Director | 306,908 | $0 | 0 (Direct) | View |
| 2020-02-03 Disposition | 2020-02-05 4:18 pm | N/A 2020-09-14 | Aevi Genomic Medicine Inc. | GNMX | BAUER EUGENE A Director | 357,816 | $0 | 0 (Direct) | View |
| 2020-02-03 Disposition | 2020-02-05 4:16 pm | N/A 2020-09-13 | Aevi Genomic Medicine Inc. | GNMX | CLEMOW ALASTAIR J Director | 291,780 | $0 | 0 (Direct) | View |
| 2020-02-03 Other | 2020-02-05 4:15 pm | N/A N/A | Aevi Genomic Medicine Inc. | GNMX | Children's Hospital of Philadelphia Foundation 10% Owner | 96,137,818 | $0 | 96,137,818 (Direct) | View |
| 2020-02-03 Disposition | 2020-02-05 4:15 pm | N/A 2022-10-17 | Aevi Genomic Medicine Inc. | GNMX | Children's Hospital of Philadelphia Foundation 10% Owner | 2,824,217 | $0 | 96,137,818 (Direct) | View |
| 2020-02-03 Disposition | 2020-02-05 4:13 pm | N/A 2024-04-16 | Aevi Genomic Medicine Inc. | GNMX | COLA MICHAEL F President and CEO | 5,759,454 | $0 | 0 (Direct) | View |
| 2020-02-03 Disposition | 2020-02-05 4:11 pm | N/A 2023-09-13 | Aevi Genomic Medicine Inc. | GNMX | NEIL GARRY ARTHUR Chief Scientific Officer | 4,352,016 | $0 | 0 (Direct) | View |
| 2019-12-05 Other | 2019-12-09 9:10 pm | N/A N/A | Aevi Genomic Medicine Inc. | GNMX | BARER SOL J Director | 2,551,020 | $0 | 5,102,040 (Indirect) | View |
| 2019-12-05 Gift | 2019-12-09 9:10 pm | N/A N/A | Aevi Genomic Medicine Inc. | GNMX | BARER SOL J Director | 519,700 | $0 | 5,102,040 (Indirect) | View |
Ownership | 2019-06-11 4:03 pm | N/A N/A | Aevi Genomic Medicine Inc. | GNMX | McInaw Michael Interim CFO | 0 | $0 | 66,857 (Direct) | View |